Drug intelligence / Profile preview

fac-[Re(bipy)(CO)3(OH2)]+

Development stage: Unknown
Modality: Small Molecules

Overview

This complex is a rhenium(I) tricarbonyl compound with a bipyridine ligand and a water molecule. Rhenium(I) tricarbonyl complexes are known for their applications in medicinal chemistry, including anticancer and antimicrobial activities, due to their biocompatibility and photoluminescent properties. The structure of this complex suggests potential biological and chemical applications, but specific details about its use or mechanism might not be well-documented in the provided sources.

Beyond the preview

Go deeper on fac-[Re(bipy)(CO)3(OH2)]+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fac-[Re(bipy)(CO)3(OH2)]+.

Explore the full profile